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europhysiologists used to view the basal gan-
glia mainly as structures for regulating voluntary move-
ment.The recent neuroanatomical,neuropsychological,
and functional imaging literature, however, has made it
increasingly clear that these subcortical structures are
also intimately involved in regulating higher cerebral
processes that control cognition, decision-making, the
planning of complex behavioral strategies, and neu-
ropsychiatric symptoms.
1,2 The frontal-subcortical cir-
cuitry provides a unifying framework for understanding
the behavioral changes that accompany neurodegener-
ative disorders.
3 In the past three decades, a number of
significant advances have been made in our under-
standing, not only of the neuroanatomy, but also of the
neurophysiology and chemoarchitecture,of the frontal-
subcortical circuits.
4 Parallelling this new understanding,
an increasingly broad spectrum of neuropsychiatric phe-
nomenology is recognized as being interpretable in the
context of frontal-subcortical circuit dysfunction. A
series of parallel segregated frontal-subcortical circuits
are now known to link specific regions of the frontal cor-
tex to the striatum, the globus pallidus (GP) and sub-
stantia nigra (SN), and the thalamus, constituting an
important effector mechanism that allows the organism
to interact adaptively with its environment.
5 Impaired
executive functions, apathy, and impulsivity are hall-
marks of frontal-subcortical circuit dysfunction. In a
recent event-related functional MRI (fMRI) study, for
instance,the authors concluded that the caudate nucleus
and the putamen are particularly important,respectively,
in the planning and the execution of a self-generated
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The neuropsychiatric manifestations of neurodegenera-
tive diseases are closely linked to neurocircuitry defects.
Frontal-subcortical circuits, in particular, are effector mech-
anisms that allow the organism to act on its environment.
In this paper, we present the three main frontal-subcorti-
cal circuits: the dorsolateral prefrontal circuit allows the
organization of information to facilitate a response; the
anterior cingulate circuit is required for motivated behav-
ior; and the orbitofrontal circuit allows the integration of
limbic and emotional information into behavioral
responses. Impaired executive functions, apathy, and
impulsivity are hallmarks of frontal-subcortical circuit dys-
function. A variety of other neuropsychiatric disorders,
such as Tourette’s syndrome, Huntington's disease, obses-
sive-compulsive disorder, attention-deficit/hyperactivity
disorder, schizophrenia, and mood disorders may result
from disturbances that have a direct or indirect impact on
the integrity or functioning of these loops.   
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6 A variety of neuropsychiatric disorders
may result from disturbances that have a direct or indi-
rect impact on the integrity or functioning of frontal-
subcortical circuits.
Background
Alexander et al
5,7-9 proposed that the basal ganglia and
thalamus participate in five parallel segregated circuits
with selected cortical areas in the frontal lobe.Two of
these circuits are related to motor function,and influence
skeletomotor and oculomotor areas of cortex. The
remaining three loops are connected with nonmotor
areas in the frontal lobe,including the dorsolateral pre-
frontal cortex,the lateral orbitofrontal cortex,and the
anterior cingulate/medial orbitofrontal cortices.These
frontal regions are known to be involved in aspects of
planning,working memory,rule-based learning,atten-
tion, and emotional regulation such as the decision
threshold in reaction time tasks or in the control of auto-
matic visuospatial attention.
10-12 Basal ganglia functional
connectivity, based on a recent meta-analysis of 126
positron emission tomography (PET) and fMRI imaging
publications,showed that patterns of functional connec-
tivity between the cortex and the striatal nuclei are
broadly consistent with the predictions of this classical
parallel loop model.
13
The frontal lobe may be viewed as comprising two dis-
tinct anatomical and functional systems,reflecting its dual
developmental origin.
14The sequential processing of sen-
sory, spatially related, and motivational information is
mediated by a dorsal system,which involves dorsolateral
and medial portions of the frontal lobes,interconnected
with the posterior parietal lobe and cingulate gyrus.
Emotional tone is mediated by a second,ventral system,
which involves the orbital surface of the frontal lobes.
The function of the frontal lobes as an integrator of infor-
mation,related both to the external sensory and internal
limbic worlds and its role in motivation and appropriate
motor response,make this region and its subcortical con-
nections critically important to an understanding of both
normal and disordered psychomotor functions.
The architectonic organization of the prefrontal cortex is
reflected in the pattern of prefrontostriatal projections.
15,16
The dorsal architectonic trend, which originates in the
rostral cingulate gyrus and culminates in the dorsal por-
tion of the frontal eye field,maps onto the dorsal caudate
nucleus.In contrast,the ventral architectonic trend,which
originates in the ventral orbital region and culminates in
the ventral portion of the frontal eye field,maps onto the
ventromedial portion of the caudate and the adjacent
portion of the nucleus accumbens.Cortical areas that are
closely connected functionally appear to send converg-
ing projections into adjacent regions of the striatum.
17-20
Information derived from the cortex is recombined at the
striatal level to form small, functionally specialized
domains.Evidence from 2-deoxyclucose metabolic stud-
ies of neuronal activation within the striatum is consis-
tent with the concept that discrete regions of the striatum
support specific functional properties.
21
Evidence for the role of a frontostriatal system in cogni-
tion and behavior was first suggested by a series of exper-
imental observations.
22 Specifically,lesions of electrical
stimulation of the dorsolateral prefrontal cortex or of the
anterodorsal head of the caudate nucleus,to which this
region projects, were found to produce deficits in the
same behavioral domain—namely,delayed-response and
delayed-alternation tasks.
23 Similarly,lesions or electrical
stimulation,either of the orbitofrontal cortex or of the
ventrolateral head of the caudate,resulted in compara-
ble deficits in object alternation or response inhibition
paradigms.
14 Accordingly, disruption to cognitive
processes following striatal injury was interpreted as the
“downstream”interruption of anatomically congruent
outflow from the frontal cortex.
24,25
Basic circuit structure
The five major frontal-subcortical circuits suggested by
Alexander et al
5,7-9 are now generally accepted. These
include a motor circuit that originates in the supplemen-
tary motor area,and an oculomotor circuit originating in
the frontal eye field.The motor circuit originates from
neurons in the supplementary motor area,premotor cor-
tex, motor cortex, and somatosensory cortex, recently
confirmed by fMRI findings.
26These areas project prin-
cipally to the putamen in a somatotopic distribution.The
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Selected abbreviations and acronyms
5-HT serotonin
GP globus pallidus
GPe globus pallidus externa
GPi ventrolateral globus pallidus interna
SN substantia nigra
SNr substantia nigra,pars reticulata
STN subthalamic nucleusputamen in turn projects to ventrolateral globus pallidus
interna (GPi),globus pallidus externa (GPe),and cau-
dolateral SN.The globus pallidus (GP) connects to the
ventrolateral, ventral anterior, and centromedianum
nuclei of the thalamus,whose major efferents are to the
supplementary motor area,premotor cortex,and motor
cortex,completing the circuit.Thalamic nuclei have rec-
iprocal connections with the putamen and cerebral cor-
tex,in addition to the connections contained within the
circuit.Throughout the circuit,the discrete somatotopic
organization of movement-related neurons is main-
tained. Information processing in the circuits is not
strictly sequential;neurophysiological investigations of
movement demonstrate preparatory premovement activ-
ity,serial processing of movements initiated in the cor-
tex,and concurrent parallel processing in the structures
of the circuit.
8,27,28The oculomotor circuit originates in the
frontal eye field (Brodmann’s area 8) as well as pre-
frontal and posterior parietal cortex, and connects
sequentially to the central body of the caudate nucleus,
dorsomedial GP and ventrolateral SN,ventral anterior
and mediodorsal thalamic nuclei,and frontal eye field.
8,9
The major frontal-subcortical circuits include three
behaviorally relevant circuits with origins in the pre-
frontal cortex: a dorsolateral prefrontal circuit, which
mediates “executive”functions (ie,the organization of
information to facilitate a response);an anterior cingu-
late circuit, which is involved in motivational mecha-
nisms
7-9 and an orbitofrontal circuit,which has lateral and
medial divisions (Figure 1).The medial portion of the
orbitofrontal circuit allows integration of visceral-amyg-
dalar functions with the internal state of the organism,
while the lateral portion is involved with integration of
limbic and emotional information into contextually
appropriate behavioral responses.Middleton and Strick
29
designate the lateral and medial portions of the
orbitofrontal circuit as two separate circuit categories and
an inferotemporal/posterior parietal circuit as an addi-
tional frontal-subcortical circuit in their revised scheme.
Common to all circuits is an origin in the frontal lobes
with projection sequentially to the striatum (caudate,
putamen, or ventral striatum), to the GP and SN, and
then to specific thalamic nuclei,with a final link back to
the frontal lobe. Each circuit has two pathways: (i) a
direct pathway,featuring a monosynaptic link between
the GPi–SN pars reticulata (SNr) complex; and (ii) an
indirect pathway that projects from striatum to GPe,link-
ing to the GPi-SNr complex via the subthalamic nucleus
(STN).
8 Both direct and indirect circuits project to the
thalamus.
The five circuits thus share common structures and are
parallel and contiguous,but remain remarkably segre-
gated anatomically,even as succeeding projections are
focused progressively onto smaller numbers of neurons.
Thus,the dorsolateral prefrontal cortex projects to the
dorsolateral region of the caudate nucleus; the lateral
orbitofrontal cortex projects to the ventral caudate area;
and the anterior cingulate cortex connects to the medial
striatal-nucleus accumbens region. Similar anatomical
arrangements are maintained in the GP and thalamus.
Although each frontal-subcortical circuit constitutes a
closed loop of anatomically segregated dedicated neu-
rons, “open”-loop elements are incorporated into the
functional connectivity of these circuits.Circuit structures
receive projections from noncircuit cortical areas,thala-
mic nuclei,and the amygdalar nuclei,and also project to
regions outside the five circuits,including inferotempo-
ral,posterior parietal,and prestriate cortex.Brain regions
linked by these afferent of efferent projections are func-
tionally related.
30-32 Circuits mediating limbic functions,
for example, have connections to other limbic areas,
whereas those involved with executive functions interact
with brain structures involved with cognition.
33 In this
way,circuits integrate information from anatomically dis-
parate but functionally related brain regions.
Examination of the open aspects of each circuit aids
understanding of how information processed in different
brain regions can be integrated and synthesized in the
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Figure 1. Pathophysiology of loop dysfunction in executive dysfunction,
apathy, and disinhibition.
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the final effector mechanism.
Many brain regions thus ultimately project through the
frontal-subcortical circuits;the direct cortical-basal gan-
glia connections go in the corticofugal direction only,and
the cortical output from these circuits (ie,the thalamo-
cortical projections) is routed primarily to the frontal cor-
tex.This suggests that,regardless of the specific nature of
the information that gains access to the frontal-subcorti-
cal circuits,the information processing that takes place
in these circuits is “formatted” for potential executive
action.
34
Dorsolateral prefrontal circuit
The dorsolateral prefrontal circuit originates in
Brodmann’s areas 9 and 10 on the lateral surface of the
anterior frontal lobe.Neurons in these regions project to
the dorsolateral head of the caudate nucleus.
35 Fibers
from this region of the caudate project to the lateral
aspect of the mediodorsal GPi and rostrolateral SNr via
the direct pathway.
36The indirect pathway sends fibers to
the dorsal GPe, which in turn projects to the lateral
STN
37;fibers from the lateral STN then terminate in the
GPi-SNr complex.Output from the basal ganglia projects
to parvocellular portions of the ventral anterior and
mediodorsal thalamus,respectively.
38,39The mediodorsal
thalamus closes the circuit by projecting back to the cir-
cuit’s origin in areas 9 and 10 of the dorsolateral frontal
lobe.
40,41
Both experimental and clinical data link the dorsolateral
prefrontal cortex and frontal-subcortical connections
with “executive function.”Executive function incorpo-
rates anticipation,goal selection,planning,monitoring,
and use of feedback in task performance.
42 Patients with
restricted dorsolateral prefrontal cortex lesions have dif-
ficulty focusing and sustaining attention, generating
hypotheses,and maintaining or shifting sets in response
to changing task demands,as required by the Wisconsin
Card Sorting Test (WCST).
14Associated features include
reduced verbal and design fluency,impairment of mem-
ory search strategies and of organizational and construc-
tional strategies on learning and copying tasks,and motor
programming disturbances.Similar syndromes have been
reported in patients with lesions of subcortical structures
of the dorsolateral prefrontal circuit.
43,44 Thus, impair-
ments on tests of memory and executive function,includ-
ing the WCST,have been noted in patients with dorsal
caudate lesions,
45 bilateral GP hemorrhages,
46 and bilat-
eral or left paramedian/mediodorsal thalamic infarc-
tion.
47,48 Executive function deficits and other features of
“subcortical” dementia
49 in such conditions as
Huntington’s disease, Parkinson’s disease, progressive
supranuclear palsy,Wilson’s disease,neuroacanthocyto-
sis,and other subcortical disorders are believed to reflect
involvement of the dorsolateral prefrontal circuit as it
projects through the basal ganglia.
43,50 In patients with
Huntington’s disease and Parkinson’s disease, perfor-
mance on tests of executive functions are correlated with
memory scores
51; the normal registration, storage, and
consolidation of memory stores is dependent on frontal
lobe function.This is consistent with evidence linking
working memory to prefrontal circuits.
52,53
In Parkinson’s disease, “frontal” functions are doubly
jeopardized by the combination of caudate nuclear
dopamine deficiency,which creates a partial “disconnec-
tion syndrome” of subcortical origin,
54-56 and the lesser
reduction of dopamine in the dorsolateral prefrontal cor-
tex.
57,58 In this disorder,specific cognitive deficits involv-
ing working memory,cognitive sequencing,and attention
shifting may respond,at least partially,to dopaminergic
therapies.
59,60This is explainable by the fact that dopamine
modulation in the basal ganglia locks the gate to work-
ing memory.
61 However,incomplete reversal of cognitive
deficits with dopamine agonists is typically noted in
Parkinson’s disease,
59 reflecting the likely role of dys-
function of nondopaminergic neuronal systems in
Parkinson’s disease dementia.
62
Psychiatric syndromes including schizophrenia,depres-
sion,and obsessive-compulsive disorder manifest execu-
tive dysfunction.The presence of executive abnormali-
ties is these disorders imply that frontal-subcortical
circuit function is compromised.Cognitive enhancement
in these disorders will focus on facilitating frontal-sub-
cortical function.
In attention-deficit/hyperactivity disorder and Tourette’s
syndrome,various agents having important effects on the
noradrenergic system,the dopaminergic system,or both
may ameliorate at least some features of executive dys-
function.
63,64 Such drugs include deprenyl,stimulant med-
ications,low-dose tricyclic antidepressants,and the α2-
adrenergic agonists clonidine and guanfacine.
65,66 Both
clonidine and guanfacine have been shown to enhance
working memory performance in aged monkeys,
67,68 and
cognitive tasks mediated by prefrontal cortex, such as
Trails B, word fluency tasks, and the Stroop task, are
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144improved by clonidine in patients with schizophrenia and
Korsakoff’s syndrome.
69,70 In patients with dementia of
the frontal lobe type,executive function may be selec-
tively enhanced by the α2-adrenergic antagonist ida-
zoxan.
71 These observations are consistent with psy-
chopharmacological and anatomical studies implicating
the noradrenergic and dopaminergic systems as impor-
tant modulators of frontal lobe function.
72
The anterior cingulate circuit
Neurons of the anterior cingulate serve as the origin of
the anterior cingulate-subcortical circuit. From
Brodmann’s area 24, they provide input to the ventral
striatum
35 which includes the ventromedial caudate,ven-
tral putamen,nucleus accumbens,and olfactory tubercle.
This area is termed the limbic striatum.
73 Projections from
the ventral striatum innervate the rostromedial GPi and
ventral pallidum (the region of the GP inferior to the
anterior commissure), as well as the rostrodorsal SN.
74
There may also be a less well-defined indirect loop pro-
jecting from the ventral striatum to the rostral pole of the
GPe.
14 The external pallidum in turn connects to the
medial STN,which returns projections to the ventral pal-
lidum.
75The ventral pallidum provides limited input to
the magnocellular mediodorsal thalamus.
74The anterior
cingulate circuit is closed with projections from the dor-
sal portion of the magnocellular mediodorsal thalamus
to the anterior cingulate.
40,76
“Akinetic mutism” is closely related to lesions to the
anterior cingulate.
77,78 It represents a wakeful state of pro-
found apathy,with indifference to pain,thirst,or hunger;
absence of motor or psychic initiative,manifested by lack
of spontaneous movement;absent verbalization;and fail-
ure to respond to questions or commands.The most dra-
matic examples of akinetic mutism follow bilateral
lesions of the anterior cingulate cortex
43,79,80 and may be
predicted by lesions that extend from the cognitive effec-
tor region posteriorly into the skeletomotor effector divi-
sion of the cingulate.
81 Unilateral lesions of the anterior
cingulate cortex tend to produce transient akinetic
mutism.
82,83 The term “abulia,” derived from the Greek
boul, or “will,”
77 refers to a similar but less severe psy-
chomotor syndrome,encompassing lack of spontaneity,
apathy,and paucity of speech and movement.
Akinetic mutism has been described with cerebrovascu-
lar disease, craniopharyngiomas, obstructive hydro-
cephalus,tumors in the region of the third ventricle,and
other conditions involving the ventral striatum (nucleus
accumbens and ventromedial caudate),ventral GP,and
medial thalamus. In an analogous syndrome, patients
with circumscribed supplementary motor area lesions
demonstrated by computed tomography (CT) may
demonstrate a disorder affecting the “drive” for both
willed movement and speech.
77 Such patients evidence
initial global akinesia and neglect,which subsequently
tends to lateralize in unilateral cases.Part of the motor
circuit,the supplementary motor area,also receives rec-
iprocal projections from the anterior cingulate.
Several studies have examined the association between
abulia or apathy and location of brain lesions.
73 Bilateral
lesions of ventrolateral and dorsomedial thalamic nuclei
frequently produce apathy.
84 Other studies have revealed
a high frequency of apathy after lesions involving the GP
and the adjacent internal capsule.
85,86 One of the main
internal pallidal outputs,which traverses the posterior
limb of the internal capsule en route to the pedunculo-
pontine nucleus,is the ansa lenticularis
77 and this path-
way may have a prominent role in goal-oriented behav-
ior.
3,87 In a review of patients with focal lesions of the
basal ganglia,
88 abulia occurred with 6 of 22 (27%)
restricted GP lesions, all bilateral, and with 18 of 64
(28%) small and large caudate lesions sparing the
lentiform nucleus, 15 of which were unilateral. In this
study,abulia was not observed with isolated putamenal
lesions,consistent with the integration of this structure
with motor rather than limbic system circuitry.
Early observations in experimental animals showed that
a syndrome similar to akinetic mutism could be produced
by bilateral or unilateral injection of 6-hydroxydopamine
into either the SN,ventral tegmental area,or nigrostri-
atal tract within the medial forebrain bundles of the lat-
eral hypothalamus.
89,90These behavioral deficits could be
reversed by administration of apomorphine, a direct
dopamine agonist,
91,92 and blocked by pretreatment 
with spiroperidol, a dopamine receptor antagonist.
93
Corroborating these observations was the initial report
of a patient with akinetic mutism after surgical removal
of a tumor from the anterior hypothalamus, who
responded to treatment with the dopamine receptor ago-
nists lergotrile and bromocriptine, but not to car-
bidopa/L-dopa or methylphenidate, presynaptic
dopamine mimetics.
94This suggested loss of dopaminer-
gic input pointed to anterior cingulate or other corticol-
imbic structures rather than to the striatum as a cause of
the patient’s akinesia.Based on pathological studies of
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14523 patients,it was subsequently postulated that isolated
damage to any of the projections of brain stem dopamin-
ergic nuclear groups could result in akinetic mutism.
95
Chronic akinetic mutism secondary to mesencephalic
infarction,destroying ventral tegmental area dopamin-
ergic neurons at their site of origin,may also be reversed
with dopamine agonists.
96,97 In children,akinetic mutism
of differing etiologies may respond to bromocriptine with
rapid and dramatic improvement,suggesting the same
pathogenesis of the disorder in childhood as in adult-
hood.
98 Response to direct dopamine agonists may be
poor,however,in cases where dopamine receptors have
been destroyed—for example, in patients with lesions
involving the anterior cingulate gyri.
Paralleling the observations in akinetic mutism, a clini-
cally significant and sustained improvement in apathy
may be seen with dopaminergic agents in a variety of
neuropsychiatric disorders.
99 Effective agents in such
conditions may include bromocriptine, amantadine,
selegiline, modafinil, buproprion, amphetamine, and
methylphenidate. Dopamine agonists, including
bromocriptine and methylphenidate, have been used
successfully to treat apathy in patients with anterior
communicating artery aneurysm,Wilson’s disease, and
human immunodeficiency virus-related dementia.
14 In a
case of successful methylphenidate treatment of apathy
secondary to cocaine-related subcortical strokes,
100
behavioral improvement was accompanied by an
increase in blood flow to the frontal cortex and selective
improvement on a reaction time version of the Stroop
task.The Stroop interference effect is associated with
cerebral activation that is most prominent in frontal and
cingulate cortex.
101
Apathy is the most commonly observed behavioral dis-
turbance in Alzheimer’s disease, and is associated with
anterior cingulate hypoperfusion.
102 The documented
improvement in Alzheimer’s-related apathy with
cholinesterase inhibitor therapy
103 may reflect partial cor-
rection of cholinergic disconnection of anterior cingulate
structures.The latter include the basal nucleus of the amyg-
dala,
81 innervated by cholinergic projections from basal
forebrain structures,and the midline thalamic nuclei,which
receive input both from the basal forebrain and from
cholinergic peduculopontine projections that form part of
the ascending reticular activating system.Patients with apa-
thy and akinetic mutism are typically alert,suggesting an
intact reticular activating system.However,partial defects
in this system may occasionally contribute to akinetic
mutism,as exemplified by a patient whose akinetic mutism
followed surgical removal of a fourth ventricular astrocy-
toma and responded well to methylphenidate.
104
Apathy is prominent in many neurodegenerative disor-
ders including frontotemporal dementia,Parkinson’s dis-
ease,and progressive supranuclear palsy.Apathy must be
distinguished from depression;apathy may occur with or
without concomitant depressive symptoms.
The orbitofrontal circuit
The lateral division of the orbitofrontal circuit originates
in the lateral orbital gyrus of Brodmann’s area 11 and the
medial inferior frontal gyrus of the areas 10 and 47 in
humans.
81These areas send projections to the ventrome-
dial caudate,which projects in turn to the most medial
portion of the mediodorsal GPi and to the rostromedial
SNr.
105The ventromedial caudate also sends an indirect
loop through the dorsal GPe to the lateral STN,which
then projects to the GPi and SNr.
75 Neurons are sent
from the GP and SN to the medial section of the mag-
nocellular division of the ventral anterior thalamus, as
well as an inferomedial sector of the magnocellular divi-
sion of the mediodorsal thalamus.
35,38This division of the
circuit then closes with projections from this thalamic
region to the lateral orbitofrontal cortex.
38
A medial division of the orbitofrontal circuit has also been
identified,originating in the inferomedial prefrontal cor-
tex, specifically the gyrus rectus and the medial orbital
gyrus of Brodmann’s area 11 in humans.
81 From this area,
the medial division has sequential projections to medial
aspects of the accumbens,to medial ventral portions of the
pallidum,and thence,via the medial magnocellular divi-
sion of the mediodorsal thalamic nucleus, back to the
medial orbitofrontal cortex.
106 The medial orbitofrontal
cortex has reciprocal connections with the medial portion
of the basal and the magnocellular division of the acces-
sory basal amygdale.Cortical areas that have reciprocal
connections with the medial orbitofrontal cortex influence
visceral function when stimulated,probably through their
shared amygdalar connections.
81 Other regions reciprocally
connected with the medial orbitofrontal cortex include the
rostral insula,ventromedial temporal pole (area 38,and
infracallosal cingulate areas 25,24,and 32,
107,108 the latter
regions being primarily part of the anterior cingulate cir-
cuit.The visceral effector areas of the infracallosal cingu-
late provides motivational tone to gustatory,olfactory,and
alimentary information converging on the medial
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146orbitofrontal cortex from the anterior insular region.The
medial division of the orbitofrontal circuit can thus be
viewed as an integrator of visceral drives while modulat-
ing the organism’s internal milieu.
81
The orbitofrontal cortex is the neocortical representation
of the limbic system
14 and is involved in the determination
of the appropriate time,place,and strategy for environ-
mentally elicited behavioral responses.Lesions in this area
appear to disconnect frontal monitoring systems from lim-
bic input,
109 resulting in behavioral disinhibition and promi-
nent emotional lability.
110 Patients lack judgment and social
tact,and may exhibit inappropriate jocularity.Decreased
impulse inhibition may be associated with improper sex-
ual remarks or gestures and with other antisocial acts,
although overt sexual aggression is rare.
14 Patients may
appear irritable,and trivial stimuli may result in outbursts
of anger that pass quickly without signs of remorse.
111
Inattention, distractibility, and increased motor activity
may be seen,and hypomania or mania is not uncommon.
112
Marked personality changes have usually been docu-
mented in the setting of bilateral orbitofrontal lobe dam-
age,
109 but circumscribed unilateral (left or right)
orbitofrontal brain injury may cause a similar personal-
ity disorder,with disinhibition,poor judgement,and irre-
sponsibility toward familial and social obligations.
113 In
patients with frontal degenerations,those affecting the
right hemisphere disproportionately are associated with
greater disinhibition and loss of socially appropriate
behavior.
114 Large bilateral orbitofrontal lobe lesions in
humans may,in addition,result in enslavement to envi-
ronmental cues,with automatic imitation of the gestures
of others, or enforced utilization of environmental
objects.
115,116 Patients with orbitofrontal dysfunction
exhibit a dissociation between impairment of behavior
necessary for activities of daily living and normal per-
formance on psychological tests sensitive to dorsolateral
prefrontal lobe dysfunction,such as the WCST.
109
Patients with ventral caudate lesions may appear disin-
hibited,euphoric,impulsive,and inappropriate,recapitu-
lating the corresponding orbitofrontal lobe syndrome.
45 It
is likely that the early appearance of similar personality
alterations in Huntington’s disease reflects the involve-
ment of medial caudate regions receiving projections from
the orbitofrontal and anterior cingulate circuits that medi-
ate limbic system function.
117 Similarly,mania may result
not only from injury to medial orbitofrontal cortex and
caudate nuclei (eg,Huntington’s disease),but also from
lesions to the right thalamus.
84,118-120 Mixed behavioral syn-
dromes commonly accompany focal lesions of the GP and
thalamus,reflecting the progressive spatial restriction of
the parallel circuits at these levels.
43
Disinhibition syndromes occur in frontotemporal demen-
tia,following closed head injury,with frontal lobe tumors,
and with focal vascular lesions.
Various pharmacological agents may be effective in mod-
ifying the disinhibited behavior of patients with
orbitofrontal circuit dysfunction,although no agent is uni-
formly reliable.
121 Potentially useful drugs include the
major and minor tranquilizers,propranolol,buspirone,car-
bamazepine,sodium valproate,lithium,and clonidine.In
addition to their dopaminergic activity,neuroleptics may
have a serotonergic mode of action in the treatment of
impulsive aggression by binding to and downregulating
the serotonin (5-HT)2 receptors,
122 a 5-HT receptor sub-
type that is represented in intermediate levels in the
nucleus accumbens and striatum.Lithium’s mood-stabi-
lizing action may be mediated by effects both on the 5-HT
system and on phosphoinositide,
123 which is selectively con-
centrated in striosomes (the striatum is organized as two
separate systems, the striosomes and the matrix) of the
medial and ventral striatum
124—regions that receive dense
orbitofrontal input.More specific serotonergic agonists,
including clomipramine and fluoxetine,may also be effec-
tive for impulsive, aggressive, or sexually disinhibited
behaviors.
125,126This may reflect serotonergic modulation of
orbitofrontal circuit dysfunction and is consistent with data
linking behavioral disinhibition with central serotonergic
deficiency.
122,126 Certain 5-HT1A agonists (“serenics”),
whose effects may be mediated by postsynaptic 5-HT1A
receptors,exert a dose-dependent decrease in aggression
with a concomitant increase in social interest in animal
paradigms.
14 Both propranolol and pindolol bind to soma-
todendritic 5-HT1A receptors, present in limbic brain
regions,
127 and appear to have 5-HT1 agonist properties at
dosages in the range of those used in the treatment of
aggressive behavior in humans.
128 Similarly, the partial 
5-HT1A agonist buspirone may be effective in the treat-
ment of aggression in a variety of neuropsychiatric condi-
tions.An orbitofrontal syndrome with mania may be seen
with bilateral orbitofrontal contusions,and may respond
rapidly to clonidine,
118 and α2-noradrenergic agonist that
reduces central noradrenergic transmission by stimulating
presynaptic autoreceptors.
129,130The response to clonidine
in such cases may be related to reduction in noradrener-
gic overactivity induced by lesions of prefrontal areas pro-
jecting to noradrenergic systems
131 which in turn innervate
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72,132 Clonidine
may ameliorate symptoms characteristic of orbitofrontal
circuit dysfunction,including inattention,distractibility,
impulsivity,and emotional lability,in patients with atten-
tion-deficit/hyperactivity disorder and Tourette’s syn-
drome.
66,133 Several classes of drugs thus have the potential
to favorably influence symptoms of orbitofrontal circuit
dysfunction, reflecting serotonergic, dopaminergic, and
noradrenergic modulation of functions of the orbitofrontal
cortex and connected brain regions.
121
Conclusions
Neuropsychiatric manifestations of neurodegenerative dis-
eases are closely linked to neurocircuitry defects.
Involvement of these circuits in a variety of neuropsychi-
atric diseases such as Tourette’s syndrome,
134,135
Huntington's disease,
136 obsessive-compulsive disorder,
137
attention-deficit/hyperactivity disorder,
138 schizophrenia,
139
and mood disorders
140 has been proposed recently.Frontal-
subcortical circuits are effector mechanisms that allow the
organism to act on the environment.The dorsolateral pre-
frontal circuit allows the organization of information to
facilitate a response; the anterior cingulate circuit is
required for motivated behavior;and the orbitofrontal cir-
cuit allows the integration of limbic and emotional infor-
mation into behavioral responses. Impaired executive
functions,apathy,and impulsivity are hallmarks of frontal-
subcortical circuit dysfunction. A variety of other neu-
ropsychiatric disorders may result from disturbances that
have a direct or indirect impact on the integrity or func-
tioning of frontal-subcortical circuits. ❏
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Circuitos fronto-subcorticales y conducta
Las manifestaciones neuropsiquiátricas de las enfer-
medades neurodegenerativas están íntimamente
relacionadas con los defectos en los neurocircuitos.
Los circuitos fronto-subcorticales son especialmente
mecanismos efectores que permiten que el orga-
nismo actúe en su ambiente. En este artículo se pre-
sentan los tres principales circuitos fronto-subcorti-
cales: el circuito prefrontal dorsolateral que permite
organizar la información para facilitar una respuesta;
el circuito cingulado anterior que necesario para la
conducta con motivación y el circuito órbito-frontal
que permite la integración de la información límbica
y emocional en respuestas conductuales. Las funcio-
nes ejecutivas deterioradas, la apatía y la impulsivi-
dad son distintivas de la disfunción del circuito
fronto-subcortical. Una variedad de otros trastornos
neuropsiquiátricos, como el Síndrome de la Tourette,
la Enfermedad de Huntingon, el trastorno obsesivo-
compulsivo, el trastorno por déficit de atención con
hiperactividad, la esquizofrenia y los trastornos del
ánimo pueden deberse a alteraciones que tengan un
impacto directo o indirecto en la integridad o el fun-
cionamiento de estos circuitos. 
Circuits fronto-sous-corticaux et 
comportement
Les manifestations neuropsychiatriques des mala-
dies neurodégénératives sont étroitement liées aux
anomalies des circuits neuronaux. Les circuits sous-
corticaux-frontaux en particulier, sont des méca-
nismes effecteurs qui permettent à l’organisme
d’agir sur son environnement. Les trois principaux
circuits fronto-sous-corticaux sont présentés dans
cet article : le circuit dorsolatéral préfrontal permet
à l’information de s’organiser pour obtenir une
réponse ; le circuit cingulaire antérieur est sollicité
pour le comportement motivé et le circuit orbito-
frontal intègre l’information limbique et émotion-
nelle dans les réponses comportementales.
L’altération des fonctions exécutives, l’apathie et
l’impulsivité sont les marques de la dysfonction des
circuits sous-corticaux-frontaux. Des perturbations
directes ou indirectes de l’intégrité du fonctionne-
ment de ces circuits peuvent entraîner d’autres
troubles neuropsychiatriques comme le syndrome
de Gilles de la Tourette, la maladie de Huntington,
les troubles obsessionnels compulsifs, les troubles
de l’attention/hyperactivité, la schizophrénie et les
troubles de l’humeur.Frontal-subcortical circuitry and behavior - Bonelli and Cummings Dialogues in Clinical Neuroscience - Vol 9 . No.2 . 2007
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